Healthcare, Regulatory and Reimbursement Landscape - IsraelReport Details:Published:December 2012No. of Pages: 145Price: S...
- Profiles and SWOT analyses of the major players in the pharmaceutical and medical devicemarkets. The key players covered...
3.2.2 Overview of the Top Five Segments 323.2.3 Major Players 433.3 Market Drivers and Barriers 613.3.1 Drivers 613.3.2 Ba...
5.4.5 Healthcare Facilities 1195.4.6 Healthcare Parameters 1235.4.7 Healthcare Personnel 1245.4.8 Environmental Health 128...
Table 14: Nephrology and Urology Devices, Israel, Revenue ($m), 2006-2011 35Table 15: Sales Trends for Major Players*, Nep...
Table 56: Births (Per 1,000 Population), Israel, Forecast, 2011-2020 104Table 57: Mortality (Per 1,000 Population), Israel...
Figure 8: Nephrology and Urology Devices, Israel, Revenue ($m), 2006-2011 35Figure 9: Sales Trends for Major Players*, Nep...
Figure 50: Major Causes of Male Mortality (Per 100,000 Population), Israel, 2009 110Figure 51: Major Causes of Female Mort...
Upcoming SlideShare
Loading in...5
×

Healthcare, Regulatory and Reimbursement Landscape - Israel

94

Published on

0 Comments
1 Like
Statistics
Notes
  • Be the first to comment

No Downloads
Views
Total Views
94
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
3
Comments
0
Likes
1
Embeds 0
No embeds

No notes for slide

Healthcare, Regulatory and Reimbursement Landscape - Israel

  1. 1. Healthcare, Regulatory and Reimbursement Landscape - IsraelReport Details:Published:December 2012No. of Pages: 145Price: Single User License – US$1995Healthcare, Regulatory and Reimbursement Landscape - IsraelSummaryGlobalData, the industry analysis specialist, has released its latest report, “Healthcare, Regulatoryand Reimbursement Landscape - Israel”. An essential source of information and analysis on theIsraeli healthcare, regulatory and reimbursement landscape, it identifies the key trends in thehealthcare market and provides insights into the demographic, regulatory, and reimbursementlandscape and healthcare infrastructure. Most importantly, the report provides valuable insightsinto the trends and segmentation of the pharmaceutical and medical device markets. It is builtusing data and information sourced from proprietary databases, secondary research and in-houseanalysis by GlobalData’s team of industry experts.In 2011, Israel’s population was 7.8 million, largely due to a positive balance between the birth rateand mortality rate. The mortality rate is declining due to improvements to healthcare infrastructureand medical and diagnostic services. The pharmaceutical market was estimated to be worth $1.78billion in 2010 and is expected to reach $2.3 billion by 2020 at a projected Compound AnnualGrowth Rate (CAGR) of 2.3%. The medical device market was worth approximately $1.2 billion in2011 and is expected to reach $1.9 billion by 2020 at a CAGR of 4.8%.These positive trends in Israel’s healthcare market can primarily be attributed to -- Growing awareness of health and well-being in society- Competitive generic market- Increasing availability of medicinesScopeThe report provides information on Israel’s healthcare, regulatory and reimbursement landscape,including -- Overview of the pharmaceutical and medical device markets, including size, segmentation, andkey drivers and barriers
  2. 2. - Profiles and SWOT analyses of the major players in the pharmaceutical and medical devicemarkets. The key players covered for the pharmaceutical market are Teva, Taro, Dexcel andRekah, and the key players covered for the medical device market are Medtronic, BostonScientific Corporation, Siemens Healthcare, B. Braun Melsungen and F. Hoffmann-La Roche.- Insightful review of the reimbursement and regulatory landscape, with details of thereimbursement process, regulatory agencies and market authorization processes for new drugand medical devices- Detailed analysis of Israel’s political and economic environment, including economic indicators,demographics, healthcare infrastructure and healthcare expenditure- An overview of the opportunities for and challenges to growth in the healthcare marketReasons to buyThe report will enhance your decision-making capability and allow you to -- Develop business strategies by understanding the trends shaping and driving the healthcaremarket- Drive revenues by understanding the key trends, reimbursement and regulatory policies,pharmaceutical and medical devices market segments and companies likely to impact thehealthcare market in the future- Formulate effective sales and marketing strategies by understanding the competitive landscapeand analyzing the performance of various competitors- Organize your sales and marketing efforts by identifying the market categories and segmentsthat present the most opportunities for consolidation, investment and strategic partnerships- Identify, understand and capitalize on the opportunities and challenges in the healthcare marketGet your copy of this report @http://www.reportsnreports.com/reports/209357-healthcare-regulatory-and-reimbursement-landscape-israel.htmlMajor points covered in Table of Contents of this report include1 Table of Contents1 Table of Contents 41.1 List of Tables 51.2 List of Figures 72 Introduction 92.1 Report Guidance 93 Overview of Pharmaceutical and Medical Device Markets 103.1 Pharmaceutical Market 103.1.1 Overview of Pharmaceutical Market 103.1.2 Market Segment 133.1.3 Major Disease Areas 143.1.4 Major Players 153.2 Medical Device Market 303.2.1 Market Overview 30
  3. 3. 3.2.2 Overview of the Top Five Segments 323.2.3 Major Players 433.3 Market Drivers and Barriers 613.3.1 Drivers 613.3.2 Barriers 624 Market Access 634.1 Reimbursement and Payer Landscape 634.1.1 Reimbursement Process 634.1.2 Overview of Insurance Providers 654.1.3 Drug Price Trend 684.1.4 Pricing Policies 694.2 Regulatory Landscape 704.2.1 Overview of Regulatory Agencies 704.2.2 New Drug Approval Process 724.2.3 Licensing Process for Pharmaceutical and Medical Device Manufacturing 724.2.4 Licensing Process for Pharmaceutical Exports and Imports 734.2.5 Intellectual Property Rights 744.2.6 Clinical Trial Regulations 754.2.7 Pharmaceutical and Medical Devices Advertising Regulations 764.2.8 Labeling and Packaging Regulations 775 Country Analysis 785.1 Political Environment 785.1.1 Political Structure 785.1.2 Analysis of Current Political Environment 795.1.3 Healthcare Policy Initiatives 805.2 Economic Landscape 815.3 Economic Indicators 825.3.1 Gross Domestic Product 825.3.2 Gross National Income 865.3.3 Inflation 875.3.4 Currency Exchange Rate 905.3.5 Foreign Direct Investment 915.3.6 Foreign Exchange Reserves 925.3.7 Trade Balance 935.3.8 Government Structural Balance 955.3.9 Government Net Debt 965.3.10 Major Industries 985.4 Demography 995.4.1 Population 995.4.2 Education and Literacy 1145.4.3 Employment 1165.4.4 Disease Burden 117
  4. 4. 5.4.5 Healthcare Facilities 1195.4.6 Healthcare Parameters 1235.4.7 Healthcare Personnel 1245.4.8 Environmental Health 1285.5 Healthcare Expenditure 1315.5.1 Major Components of Healthcare Spending 1325.5.2 Share of Public and Private Sector in Healthcare 1335.5.3 Healthcare Expenditure by Financing Agent 1345.5.4 Spending in Science and Technology R&D 1355.6 Trade Associations 1365.6.1 Pharmaceutical Association of Israel 1365.6.2 Pharma Israel 1365.7 Trade Fairs 1376 Opportunities and Challenges 1386.1 Opportunities 1386.2 Challenges 1397 Appendix 1407.1 Abbreviations 1407.2 Bibliography 1417.3 Methodology 1447.3.1 Coverage 1447.3.2 Secondary Research 1447.3.3 Forecasting 1447.3.4 Primary Research 1457.3.5 Expert Panel Validation 1457.4 Contact Us 1457.5 Disclaimer 1451.1 List of TablesTable 1: Pharmaceutical Market, Israel, Revenue ($bn), 2005-2010 11Table 2: Pharmaceutical Market, Israel, Revenue ($bn), 2011-2020 12Table 3: Major Biotechnology Companies and Products, 2011 13Table 4: Major Products, Teva, Global, Revenue ($m), 2011 15Table 5: Late-stage Pipeline, Teva, 2012 16Table 6: Major Products, Taro, 2012 20Table 7: Major Products, Dexcel Pharma, 2012 23Table 8: Major Products, Rekah Pharmaceutical, 2012 27Table 9: Medical Device Market, Israel, Revenue ($m), 2006-2011 30Table 10: Medical Device Market, Israel, Revenue Forecast ($m), 2012-2020 31Table 11: Medical Device Market, Israel, Segments, Revenue ($m), 2011 32Table 12: Cardiovascular Devices Market, Israel, Revenue ($m), 2006-2011 33Table 13: Sales Trends for Major Players*, Cardiovascular Devices, Israel, 2011 34
  5. 5. Table 14: Nephrology and Urology Devices, Israel, Revenue ($m), 2006-2011 35Table 15: Sales Trends for Major Players*, Nephrology and Urology Devices, Israel, 2011 36Table 16: In Vitro Diagnostics Market, Israel, Revenue ($m), 2006-2011 37Table 17: Sales Trends for Major Players*, In Vitro Diagnostics Devices, Israel, 2010 38Table 18: Ophthalmic Devices Market, Israel, Revenue ($m), 2006-2011 39Table 19: Sales Trends for Major Players*, Ophthalmic Devices, Israel, 2010 40Table 20: Orthopedic Devices Market, Israel, Revenue ($m), 2006-2011 41Table 21: Sales Trends for Major Players*, Orthopedic Devices, Israel, 2011 42Table 22: Major Medical Device Companies, Israel, Revenues ($m), 2010 43Table 23: Major Products, Medtronic, Global, Revenue ($m), 2011 44Table 24: Major Products, Boston, Global, Revenue ($m), 2010 49Table 25: Major Products, Siemens Healthcare, Revenue ($m), 2012 51Table 26: Late-stage Pipeline, Siemens Healthcare, 2012 52Table 27: Major Product Division, B. Braun, Global, Revenue ($m), 2011 55Table 28: Major Products, Roche, Global Revenues ($m), 2012 58Table 29: Late-stage Pipeline, Roche, 2012 58Table 30: Healthcare Spending, Israel, Patient Share (%), 2005-2010 66Table 31: HMOs, Israel, Co-payment Cap for Chronically Ill Patients (NIS), 2012 66Table 32: Drug Price Trends (%), Israel, 2006-2011 68Table 33: HMOs, Israel, Co-payments for Chronically Ill Patients (NIS) (%), 2012 69Table 34: GDP Per Capita ($’000), Israel, 2006-2011 82Table 35: GDP Per Capita ($’000), Israel, Forecast, 2012-2020 83Table 36: GDP, Annual Growth (%), Israel, 2006-2011 84Table 37: GDP, Annual Growth (%), Israel, Forecast, 2012-2020 85Table 38: GNI Per Capita ($’000), Israel, 2006-2011 86Table 39: Average Consumer Price Index, Israel, 2006-2011 87Table 40: Average Consumer Price Index, Israel, Forecast, 2012-2020 88Table 41: Average Consumer Price, Israel, Annual Change (%), 2006-2011 89Table 42: Currency Exchange Rate (NIS/$), Israel, 2006-2011 90Table 43: Foreign Direct Investment ($bn), Israel, 2006-2011 91Table 44: Foreign Exchange Reserves ($bn), Israel, 2006-2011 92Table 45: Imports of Goods and Services ($bn), Israel, 2006-2011 93Table 46: Exports of Goods and Services ($bn), Israel, 2006-2011 94Table 47: General Government Structural Balance ($bn), Israel, 2005-2010 95Table 48: General Government Net Debt ($bn), Israel, 2005-2010 96Table 49: General Government Net Debt ($bn), Israel, Forecast, 2011-2020 97Table 50: Major Industry Sectors, Net Domestic Product ($bn), Israel, 2010 98Table 51: Population (‘000), Israel, 2006-2011 99Table 52: Population (‘000), Israel, Forecast, 2012-2020 100Table 53: Urban and Rural Population, Israel, Share (%), 2005-2010 101Table 54: Age Groups, Israel, Population Distribution (%), 2005-2010 102Table 55: Births (Per 1,000 Population), Israel, 2005-2010 103
  6. 6. Table 56: Births (Per 1,000 Population), Israel, Forecast, 2011-2020 104Table 57: Mortality (Per 1,000 Population), Israel, 2006-2011 105Table 58: Mortality (Per 1,000 Population), Israel, Forecast, 2012-2020 106Table 59: Major Causes of Mortality (Per 100,000 Population), Israel, 2009 107Table 60: Infant Mortality (Per 1,000 Live Births), Israel, 2006-2011 108Table 61: Immunization Rate for MMR, DPT, Hib, HBV (%), Israel, 2005-2010 109Table 62: Major Causes of Male Mortality (Per 10,0000 Population), Israel, 2009 110Table 63: Major Causes of Female Mortality (Per 100,000 Population), Israel, 2009 111Table 64: Gender Ratio (M/F), Israel, 2005-2010 112Table 65: Life Expectancy at Birth (Years), Israel, 2005-2010 113Table 66: National Expenditure, Israel, Education and Literacy (% of GDP), 2005-2010 114Table 67: National Expenditure, Israel, Level of Education (%), 2007 115Table 68: Unemployment Rate (%), Israel, 2005-2010 116Table 69: Most Frequently Diagnosed Diseases (‘000), Israel, 2009 117Table 70: Major Diseases, Israel, DALYs (Per 100,000 Population), 2004 118Table 71: Total Number of Hospitals, Israel, 2005-2010 119Table 72: Public and Private Hospitals, Israel, 2005-2010 120Table 73: Types of Hospital, Israel, 2008-2010 121Table 74: Long-term Care Hospitals, Israel, 2008-2010 122Table 75: Hospital Beds (Per 1,000 Population), Israel, 2005-2010 123Table 76: Doctors (Per 1,000 Population), Israel, 2005-2010 124Table 77: Dentists (Per 1,000 Population), Israel, 2006-2011 125Table 78: Nurses (Per 1,000 Population), Israel, 2006-2011 126Table 79: Pharmacists (Per 1,000 Population), Israel, 2006-2011 127Table 80: PM10 (µg/m3), Israel, 2005-2010 128Table 81: CO2 Emissions (‘000 Tons), Israel, 2005-2010 129Table 82: NOx, CO, SO2 Emissions (Tons), Israel, 2005-2010 130Table 83: Healthcare Expenditure (% of GDP), Israel, 2005-2010 131Table 84: Healthcare Expenditure, Israel, Types of Services (%), 2008 132Table 85: Healthcare Expenditure, Israel, Public-Private Share (%), 2005-2010 133Table 86: Healthcare Expenditure, Israel, Financing Agent (%), 2008 134Table 87: R&D Expenditure, Israel, Science and Technology ($bn), 2005-2010 135Table 88: Major Healthcare Trade Fairs, Israel, 2013-2014 1371.2 List of FiguresFigure 1: Pharmaceutical Market, Israel, Revenue ($bn), 2005-2010 11Figure 2: Pharmaceutical Market, Israel, Revenue, Forecast ($bn), 2011-2020 12Figure 3: Medical Device Market, Israel, Revenue ($m), 2006-2011 30Figure 4: Medical Device Market, Israel, Revenue Forecast ($m), 2012 --2020 31Figure 5: Medical Device Market, Israel, Segments, Revenue ($m), 2011 32Figure 6: Cardiovascular Devices Market, Israel, Revenue ($m), 2006-2011 33Figure 7: Sales Trends for Major Players*, Cardiovascular Devices, Israel, 2006-2011 34
  7. 7. Figure 8: Nephrology and Urology Devices, Israel, Revenue ($m), 2006-2011 35Figure 9: Sales Trends for Major Players*, Nephrology and Urology Devices, Israel, 2006-2011 36Figure 10: In Vitro Diagnostics Market, Israel, Revenue ($m), 2006-2011 37Figure 11: Sales Trends for Major Players*, In Vitro Diagnostics Devices, Israel, 2006-2010 38Figure 12: Ophthalmic Devices Market, Israel, Revenue ($m), 2006-2011 39Figure 13: Sales Trends for Major Players*, Ophthalmic Devices, Israel, 2006-2010 40Figure 14: Orthopedic Devices Market, Israel, Revenue ($m), 2006-2011 41Figure 15: Sales Trends for Major Players*, Orthopedic Devices, Israel, 2006-2011 42Figure 16: Major Medical Device Companies, Israel, Revenues ($m), 2010 43Figure 17: Drivers and Barriers, Healthcare Market, Israel, 2012 62Figure 18: Overview of Healthcare System, Israel, 2012 64Figure 19: Healthcare Spending, Israel, Patient Share (%), 2005-2010 66Figure 20: Drug Price Trends (%), Israel, 2006-2011 68Figure 21: Overview of Regulatory Bodies, Israel, 2012 71Figure 22: GDP Per Capita ($’000), Israel, 2006-2011 82Figure 23: GDP Per Capita ($’000), Israel, Forecast, 2012-2020 83Figure 24: GDP, Annual Growth (%), Israel, 2006-2011 84Figure 25: GDP, Annual Growth (%), Israel, Forecast, 2012-2020 85Figure 26: GNI Per Capita ($’000), Israel, 2006-2011 86Figure 27: Average Consumer Price Index, Israel, 2006-2011 87Figure 28: Average Consumer Price Index, Israel, Forecast, 2012-2020 88Figure 29: Average Consumer Price, Israel, Annual Change (%), 2006-2011 89Figure 30: Currency Exchange Rate (ILS/$), Israel, 2006-2011 90Figure 31: Foreign Direct Investment ($bn), Israel, 2006-2011 91Figure 32: Foreign Exchange Reserves ($bn), Israel, 2006-2011 92Figure 33: Imports of Goods and Services ($bn), Israel, 2006-2011 93Figure 34: Exports of Goods and Services ($bn), Israel, 2006-2011 94Figure 35: General Government Structural Balance ($bn), Israel, 2005-2010 95Figure 36: General Government Net Debt ($bn), Israel, 2005-2010 96Figure 37: General Government Net Debt ($bn), Israel, Forecast, 2011-2020 97Figure 38: Major Industry Sectors, Net Domestic Product ($bn), Israel, 2010 98Figure 39: Population (000’s), Israel, 2006-2011 99Figure 40: Population (000’s), Israel, Forecast, 2012-2020 100Figure 41: Urban and Rural Population, Israel, Share (%), 2005-2010 101Figure 42: Age Groups, Israel, Population Distribution (%), 2005-2010 102Figure 43: Births (Per 1,000 Population), Israel, 2005-2010 103Figure 44: Births (Per 1,000 Population), Israel, Forecast, 2011-2020 104Figure 45: Mortality (Per 1,000 Population), Israel, 2006-2011 105Figure 46: Mortality (Per 1,000 Population), Israel, Forecast, 2012-2020 106Figure 47: Major Causes of Mortality (Per 100,000 Population), Israel, 2009 107Figure 48: Infant Mortality (Per 1,000 Live Births), Israel, 2006-2011 108Figure 49: Immunization Rate for MMR, DPT, Hib, HBV (%), Israel, 2005-2010 109
  8. 8. Figure 50: Major Causes of Male Mortality (Per 100,000 Population), Israel, 2009 110Figure 51: Major Causes of Female Mortality (Per 10,0000 Population), Israel, 2009 111Figure 52: Gender Ratio (M/F), Israel, 2005-2010 112Figure 53: Life Expectancy at Birth (Years), Israel, 2005-2010 113Figure 54: National Expenditure, Israel, Education and Literacy (% of GDP), 2005-2010 114Figure 55: National Expenditure, Israel, Level of Education (%), 2007 115Figure 56: Unemployment Rate (%), Israel, 2005-2010 116Figure 57: Most Frequently Diagnosed Diseases (‘000), Israel, 2009 117Figure 58: Major Diseases, Israel, DALYs (Per 100,000 Population), 2004 118Figure 59: Total Number of Hospitals, Israel, 2005-2010 119Figure 60: Public and Private Hospitals, Israel, 2005-2010 120Figure 61: Types of Hospital, Israel, 2008-2010 121Figure 62: Long-term Care Hospitals, Israel, 2008-2010 122Figure 63: Hospital Beds (Per 1,000 Population), Israel, 2005-2010 123Figure 64: Doctors (Per 1,000 Population), Israel, 2005-2010 124Figure 65: Dentists (Per 1,000 Population), Israel, 2006-2011 125Figure 66: Nurses (Per 1,000 Population), Israel, 2006-2011 126Figure 67: Pharmacists (Per 1,000 Population), Israel, 2006-2011 127Figure 68: PM10 (µg/m3), Israel, 2005-2010 128Figure 69: CO2 Emissions (‘000 Tons), Israel, 2005-2010 129Figure 70: NOx, CO, SOX Emissions (Tons), Israel, 2005-2010 130Figure 71: Healthcare Expenditure (% of GDP), Israel, 2005-2010 131Figure 72: Healthcare Expenditure, Israel, Types of Services (%), 2008 132Figure 73: Healthcare Expenditure, Israel, Public-Private Share (%), 2005-2010 133Figure 74: Healthcare Expenditure, Israel, Financing Agent (%), 2008 134Figure 75: R&D Expenditure, Israel, Science and Technology ($bn), 2005-2010 135Figure 76: Opportunities and Challenges, Healthcare Market, Israel, 2012 139Contact: sales@reportsandreports.com for more information.

×